New Her2 clinical trial phase III starting

Options
wishiwere
wishiwere Member Posts: 3,793
edited June 2014 in HER2+ (Positive) Breast Cancer
New Her2 clinical trial phase III starting
· Share on FacebookShare on Twitter

Comments

  • wishiwere
    wishiwere Member Posts: 3,793
    edited October 2008

    Sounded promising, and although I'm not Her2 positive, thought I should share with those who are here.

    http://www.apthera.com/products.php?id=3

    Apthera is completing Phase II clinical trials with NeuVax for the adjuvant treatment of early stage, HER2/neu-positive breast cancer. Results from two trials have shown that NeuVax reduces recurrence rates while showing minimal toxicity.

    Planning is underway for a large Phase III clinical trial of NeuVax to prove the safety and efficacy of the product and prepare it for market. Apthera will seek FDA approval of NeuVax for the adjuvant treatment of node-positive breast cancer in women with low to intermediate levels of HER2/neu expression.

    · Share on FacebookShare on Twitter
  • Maryiz
    Maryiz Member Posts: 975
    edited October 2008

    Wishiwere, thanks for staying on top of the research.  I, also, am not HER2 positive, but I am so happy for those that are.  This sounds incredibly promising.  Maryiz

    · Share on FacebookShare on Twitter

Categories